SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-22-032265
Filing Date
2022-06-10
Accepted
2022-06-10 16:43:31
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea161364-f1_nlspharma.htm F-1 200834
2 OPINION OF WENGER VIELI AG, SWISS COUNSEL TO NLS PHARMACEUTICS LTD ea161364ex5-1_nlspharma.htm EX-5.1 33831
3 CONSENT OF PRICEWATERHOUSECOOPERS AG ea161364ex23-1_nlspharma.htm EX-23.1 2449
4 FILING FEE TABLE ea161364ex-fee_nlspharma.htm EX-FILING FEES 14581
5 GRAPHIC image_001.jpg GRAPHIC 36196
6 GRAPHIC ex23-1_001.jpg GRAPHIC 1882
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3283
  Complete submission text file 0001213900-22-032265.txt   310044
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-265529 | Film No.: 221009528
SIC: 2834 Pharmaceutical Preparations